Beaumont Financial Partners, LLC Amgen Inc Transaction History

Beaumont Financial Partners, LLC

$1.04 Billion
Q3 2022

A detailed history of Beaumont Financial Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 4,814 shares of AMGN stock, worth $1.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,814

Previous 4,814 -0.0%

Holding current value

$1.5 Million

Previous $1.17 Million 7.34%

% of portfolio

0.1%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $83,055 - $92,426	-360 Reduced 6.96%	4,814 $1.17 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $97,794 - $108,186	446 Added 9.43%	5,174 $1.25 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $25,257 - $28,905	-127 Reduced 2.62%	4,728 $1.06 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $212 - $248	-1 Reduced 0.02%	4,855 $1.03 Million
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $295,712 - $328,071	1,266 Added 35.26%	4,856 $1.18 Million

Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $232,561 - $271,012	-1,048 Reduced 22.6%	3,590 $1.21 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $117,710 - $140,172	544 Added 13.29%	4,638 $1.07 Million
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $18,068 - $20,093	77 Added 1.92%	4,094 $1.04 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $1,186 - $1,456	-6 Reduced 0.15%	4,017 $948,000
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $8,018 - $10,634	-44 Reduced 1.08%	4,023 $816,000
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $42,572 - $54,720	225 Added 5.86%	4,067 $981,000
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $668,930 - $801,518	3,842 New	3,842 $743,000

Others Institutions Holding AMGN

# of Institutions

2,934

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.

Account

Beaumont Financial Partners, LLC Amgen Inc Transaction History